Skip to main content
Fanli Digital Technology Co., Ltd logo

Fanli Digital Technology Co., Ltd — Investor Relations & Filings

Ticker · 600228 ISIN · CNE000000Y78 Shanghai Stock Exchange Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 2,251 across all filing types
Latest filing 2019-04-28 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 600228

About Fanli Digital Technology Co., Ltd

https://corp.fanli.com/

Fanli Digital Technology Co., Ltd. provides e-commerce integration and digital marketing services. The company operates a comprehensive platform that connects consumers with various online retail ecosystems through value-added services such as cash-back rewards, discount coupons, and promotional insights. Its core business model focuses on performance-based marketing, utilizing data-driven strategies to facilitate sales conversions for brand partners. Key offerings include brand promotion, user loyalty management, and targeted advertising solutions. By integrating diverse shopping channels into a single interface, the company optimizes the consumer purchasing journey and provides brands with scalable traffic acquisition tools. The platform serves as a strategic intermediary, leveraging user behavioral data to enhance marketing efficiency and provide measurable returns for merchants while delivering cost savings to a broad user base.

Recent filings

Filing Released Lang Actions
独立董事关于第七届董事会第九次会议相关议案的独立意见
Audit Report / Information Classification · 95% confidence The document is an independent directors' opinion on various proposals discussed at the company's seventh board's ninth meeting. It includes opinions on the 2018 profit distribution plan, internal control evaluation report, future shareholder return plan, audit fee payment, reappointment of the audit firm, asset impairment provision, and write-off of long-term equity investments. The document is not a full audit report or annual report but rather an opinion on board meeting proposals related to financial and audit matters. It is a standalone audit-related opinion document, not a full financial report or announcement of a report publication. Therefore, it fits best under Audit Report / Information (AR). The document length is 2055 characters, which is short but contains substantive audit-related content, not just an announcement or certification. Hence, classification as AR is appropriate with high confidence. FY 2018
2019-04-28 Chinese
关于注销控股子公司的公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement by the company Jiangxi Changjiu Biochemical Co., Ltd. regarding the cancellation (注销) of a controlling subsidiary. It includes details about the subsidiary, reasons for cancellation, and the impact on the company. The document is short (1316 characters) and does not contain financial statements or detailed financial analysis. It is an announcement of a corporate action related to the company's capital structure and subsidiary status, specifically about the cancellation of a controlling subsidiary. This fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as subsidiary cancellations or restructurings. It is not an annual or interim report, audit report, or other categories. Therefore, the classification is CAP with high confidence.
2019-04-28 Chinese
江西昌九生物化工股份有限公司内控审计报告（中兴财光华审专字[2019]第213052号）
Audit Report / Information Classification · 95% confidence The document is titled '内部控制审计报告' which translates to 'Internal Control Audit Report'. It is issued by a certified public accounting firm and addresses the effectiveness of internal control over financial reporting as of December 31, 2018. The content includes auditor responsibilities, management responsibilities, and an audit opinion on internal control effectiveness. There is no indication that this is a full annual report or interim financial report, but rather a standalone audit report focused on internal controls. The document length is about 4541 characters, which is sufficient to contain the full audit report text rather than just an announcement. Therefore, this document fits the category of an Audit Report / Information (AR).
2019-04-28 Chinese
未来三年股东回报规划（2019-2021年）
Notice of Dividend Amount Classification · 95% confidence The document is titled '江西昌九生物化工股份有限公司未来三年股东回报规划（2019-2021年）' which translates to 'Future Three-Year Shareholder Return Plan (2019-2021)'. It details the company's dividend policy, conditions for cash dividends, stock dividends, and the decision-making process for shareholder returns over a multi-year period. The content focuses on dividend planning and shareholder return strategy rather than announcing a specific dividend amount or payment date. It is not a short announcement or a report publication notice but a detailed policy document. This fits best under the category of Notice of Dividend Amount (DIV) as it outlines the dividend distribution plan and policy for shareholders over the next three years, including minimum dividend payout ratios and conditions for dividends. The document is 1908 characters long, which is relatively short but contains substantive policy details rather than just an announcement or a report publication. Therefore, the most appropriate classification is DIV with high confidence.
2019-04-28 Chinese
关于修改《公司章程》的公告
Governance Information Classification · 95% confidence The document is an announcement from Jiangxi Changjiu Biochemical Co., Ltd. regarding amendments to the company's Articles of Association (公司章程). It details specific changes to the company's bylaws, including governance structure, share repurchase conditions, and board responsibilities. The document is a formal notice of proposed changes to corporate governance documents, not a full report or financial statement. It does not contain financial data, earnings, or audit information. It is not a report publication announcement since it contains substantive content about the amendments themselves. The nature of the document aligns with Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2019-04-28 Chinese
独立董事对公司当期及累计对外担保情况的专项说明及独立意见
Regulatory Filings Classification · 95% confidence The document is a special statement and independent opinion by the independent directors of Jiangxi Changjiu Bio-chemical Co., Ltd. regarding the company's external guarantees during the reporting period. It references regulatory notices from the China Securities Regulatory Commission and discusses compliance with laws and internal regulations on external guarantees. The document is a formal attestation and opinion rather than a full financial report or audit. It does not contain comprehensive financial statements or detailed financial analysis. It is not an announcement of a report but a standalone statement related to regulatory compliance and governance. Therefore, it fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and attestations that do not fit other categories.
2019-04-28 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.